Literature DB >> 17494108

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.

C Mitea1, R Havenaar, J Wouter Drijfhout, L Edens, L Dekking, F Koning.   

Abstract

BACKGROUND: Coeliac disease is caused by an immune response to gluten. As gluten proteins are proline rich they are resistant to enzymatic digestion in the gastrointestinal tract, a property that probably contributes to the immunogenic nature of gluten. AIMS: This study determined the efficiency of gluten degradation by a post-proline cutting enzyme, Aspergillus niger prolyl endoprotease (AN-PEP), in a dynamic system that closely mimics the human gastrointestinal tract (TIM system).
METHODS: Two experiments were performed. In the first, a slice of bread was processed in the TIM system with and without co-administration of AN-PEP. In the second, a standard fast food menu was used. Samples of the digesting meals were taken from the stomach, duodenum, jejunum and ileum compartments at time zero until 4 hours after the start of the experiment. In these samples the levels of immunogenic peptides from gliadins and glutenins were assessed by monoclonal antibody-based competition assays, Western blot analysis and proliferation T-cell assays.
RESULTS: AN-PEP accelerated the degradation of gluten in the stomach compartment to such an extent that hardly any gluten reached the duodenum compartment.
CONCLUSION: AN-PEP is capable of accelerating the degradation of gluten in a gastrointestinal system that closely mimics in-vivo digestion. This implies that the co-administration of AN-PEP with a gluten-containing meal might eliminate gluten toxicity, thus offering patients the possibility of abandoning (occasionally) their strict gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494108     DOI: 10.1136/gut.2006.111609

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  70 in total

Review 1.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

Review 2.  Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Authors:  Valli De Re; Maria Paola Simula; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

3.  [New therapeutic approaches to special diseases of the small intestine].

Authors:  M Schumann; K Herrlinger; M Zeitz; E F Stange
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

4.  Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.

Authors:  S M Stenman; K Lindfors; J I Venäläinen; A Hautala; P T Männistö; J A Garcia-Horsman; A Kaukovirta-Norja; S Auriola; T Mauriala; M Mäki; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2010-06-15       Impact factor: 4.330

Review 5.  Celiac disease: advances in treatment via gluten modification.

Authors:  Samantha Stoven; Joseph A Murray; Eric Marietta
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 6.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

7.  Transcriptome analysis of a barley breeding program examines gene expression diversity and reveals target genes for malting quality improvement.

Authors:  María Muñoz-Amatriaín; Yanwen Xiong; Mark R Schmitt; Hatice Bilgic; Allen D Budde; Shiaoman Chao; Kevin P Smith; Gary J Muehlbauer
Journal:  BMC Genomics       Date:  2010-11-23       Impact factor: 3.969

8.  Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates.

Authors:  Gregor Fuhrmann; Andrea Grotzky; Ružica Lukić; Simon Matoori; Paola Luciani; Hao Yu; Baozhong Zhang; Peter Walde; A Dieter Schlüter; Marc A Gauthier; Jean-Christophe Leroux
Journal:  Nat Chem       Date:  2013-06-09       Impact factor: 24.427

Review 9.  Non-dietary forms of treatment for adult celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 10.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.